Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...

Antibody Actions

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Postoperative changes in cervical hemodynamics and cognitive function following cervical lymphatic-venous surgery in Alzheimer's disease.

Journal of Alzheimer's disease : JAD·2026

Same author

Regulatory T cells sabotage anti-tumor γδ T cells by creating IL-2-deficient environments.

The Journal of experimental medicine·2026

Same author

Glutathione-Responsive Fragmentation of Heteronorbornadiene-Based Thiovinyl Sulfones in Glioma Cells.

Bioconjugate chemistry·2026

Same author

Selective TRPV2 Antagonists Derived from the Natural Product Piperlongumine Inhibit Cancer Cell Migration and Metastasis.

ACS chemical biology·2026

Same author

A Bifunctional Small Molecule Degrader of the Long Noncoding RNA MALAT1 Triplex.

Chemistry (Weinheim an der Bergstrasse, Germany)·2026

Same author

Controlled Self-Immolative Release of β-Lapachone via an Optimized <i>para</i>-Hydroxybenzyl Linker for Targeted Pancreatic Cancer Therapy.

Journal of the American Chemical Society·2025

Search research articles

Related Experiment Video

Updated: Jun 26, 2025

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

Homogeneous multi-payload antibody-drug conjugates.

Toby Journeaux¹, Gonçalo J L Bernardes^2,3

¹Department of Chemistry, University of Cambridge, Cambridge, UK.

Nature Chemistry

|May 17, 2024

Summary

Researchers are developing antibody-drug conjugates (ADCs) with multiple drug payloads to enhance cancer treatment efficacy and combat drug resistance, moving beyond single-payload designs.

More Related Videos

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

Related Experiment Videos

Last Updated: Jun 26, 2025

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

Area of Science:

Biotechnology
Oncology
Medicinal Chemistry

Background:

Current antibody-drug conjugates (ADCs) utilize a single drug payload.
Combination chemotherapy improves cancer treatment by synergistic effects and preventing drug resistance.
There is a need to develop multi-payload ADCs to enhance targeted therapy efficacy.

Purpose of the Study:

To review and compare methods for generating homogeneous multi-payload ADCs.
To provide an overview of single- and multi-payload ADC generation techniques.
To critically evaluate the successes and challenges in multi-payload ADC development.

Main Methods:

Summarizing and comparing various ADC generation methods.
Discussing techniques like branched linker installation and unnatural amino acid incorporation.
Providing a comparison tool for modification strategies.

Main Results:

Multiple methods exist for creating homogeneous multi-payload ADCs.
These methods address the complexity of attaching unique payloads to antibodies.
Preclinical and clinical results of these ADCs are being evaluated.

Conclusions:

Developing multi-payload ADCs is a rapidly growing research area.
Challenges remain in the generation and application of these complex constructs.
Future research should focus on optimizing these advanced targeted therapies.